The mechanism of action of radiosensitization of conventional chemotherapeutic agents.
about
Differential role of RB in response to UV and IR damage.The crystal structure analysis of the relative binding of cisplatin and carboplatin in a mixture with histidine in a protein studied at 100 and 300 K with repeated X-ray irradiationChemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumorsInhibition of c-Jun N-terminal kinase activity enhances vestibular schwannoma cell sensitivity to gamma irradiation.Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical libraryGemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I studySafety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancerCan drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro dataRadiosensitization of human breast cancer cells to ultraviolet light by 5-fluorouracil.Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patientsEnhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival.Role of cell cycle in epidermal growth factor receptor inhibitor-mediated radiosensitization.Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer.Etoposide sensitizes CT26 colorectal adenocarcinoma to radiation therapy in BALB/c mice.Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials.Effects of base excision repair gene polymorphisms on pancreatic cancer survivalCurrent status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer.Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro.CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation.Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features.Preoperative versus postoperative treatment for locally advanced rectal carcinoma.p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced deathNew and emerging radiosensitizers and radioprotectors.Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51.Motexafin gadolinium: a novel radiosensitizer for brain tumors.Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application.Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancerThe status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.Aspiration in head and neck cancer patients: a single centre experience of clinical profile, bacterial isolates and antibiotic sensitivity pattern.Stomach cancer risk after treatment for hodgkin lymphoma.Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a reviewIn vivo efficacy of marimastat and chemoradiation in head and neck cancer xenograftsThe radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells.9-bromonoscapine-induced mitotic arrest of cigarette smoke condensate-transformed breast epithelial cells.A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments.Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?
P2860
Q24802969-0D1BD2CA-FEF9-4DE4-9688-8D77A8F55D11Q27683672-83F2A8CE-B057-4601-8857-C962B7FE5788Q28474893-AB4A1F83-C812-41DA-BBA4-C7D3F959648DQ30419586-CD07FE37-AC92-4AF1-B61D-FB9959AC3402Q30422607-95601634-D75D-406B-A0C9-B717A8FA2A70Q33299295-002CEB35-0DEC-417A-8BA7-AC79F6518397Q33365043-77EEF36D-180F-406A-987E-52E92BF07528Q33778223-82459963-7202-4B57-B9C2-8BFC8C7D5B77Q34134930-8CC3D76C-3C8F-4089-9E70-B1BC98D495E4Q34367141-38BAA3F9-9168-41B7-94AF-32EAE320F97BQ34369205-B02226EC-B749-4CCF-85BD-648D878FF5B3Q34402129-574AC49D-27DB-4EA2-9BD8-E39DFE08A81AQ34619179-5C12AF64-5432-447B-9FEC-9EF74F43C59DQ34985788-30F24D36-71AC-4FE7-AA35-6A7944052D86Q35130362-0220E91F-3045-4D40-8374-8CF9332CDD31Q35435861-3BCB3F71-FD48-4DDA-9A1C-33BA17F21219Q35555777-D932C11F-1A20-4AE8-9849-D58CECF69710Q35842670-9AFFB504-E9D9-43CA-A9F1-6791FAAC7793Q35987944-75221C7B-05C8-42EC-8DEA-E6815EFA667DQ36027858-9D76AC08-006C-4AE8-A8EA-9522C76E0657Q36206168-AE69A4DF-5F42-4CEA-8E60-F8E5FAEE258EQ36216266-1ABBA54C-A289-49C1-B649-0A1858E084A2Q36429439-AE26A168-6ADC-4684-BE8A-F556CFF6367EQ36445874-BD2A6FF4-08DC-43FB-B1BC-E0E75165DE8AQ36508097-608D8DC7-DC05-4B8D-B8C6-EA70405D4E9DQ36674828-62F86275-DBB0-4F42-9828-CB61C0DC518AQ36842747-6BAEF689-5D47-43B7-83C5-EADBCD01C85CQ36844934-214F0DCE-400E-4D27-8FC7-F8DDFF300184Q37002085-AC02F5BA-D3BD-47DC-89DD-5FC240D09054Q37015715-D100AFF8-BEAE-4DBA-A107-1E5C5878ABA0Q37034144-868D6E15-6E19-4732-B299-6EBF1DA55B66Q37165088-658DC877-31BC-4914-BF8A-FD92E80F67AEQ37230970-A45DB3A7-CE92-48AB-9980-66C7E39CD780Q37238120-0AB8FF80-312E-4DB8-BB75-3EAF93073F68Q37276709-1C849DF3-2637-4514-99BF-D3BB58CE9930Q37308971-673FFD4D-0187-4778-891F-B66ED7851BB2Q37333621-4E15065E-9631-4A8D-B169-E648581ECF2BQ37412251-B4397911-AAF2-42D5-BDE6-09E92439F6A5Q37437083-32F82778-CF81-4BA0-B376-335D5299DB54Q37697800-84FBD3F1-FFB8-4CE0-B12D-524E4FD5AA12
P2860
The mechanism of action of radiosensitization of conventional chemotherapeutic agents.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The mechanism of action of radiosensitization of conventional chemotherapeutic agents.
@en
type
label
The mechanism of action of radiosensitization of conventional chemotherapeutic agents.
@en
prefLabel
The mechanism of action of radiosensitization of conventional chemotherapeutic agents.
@en
P2093
P921
P356
P1476
The mechanism of action of radiosensitization of conventional chemotherapeutic agents.
@en
P2093
A William Blackstock
Cornelius McGinn
Theodore S Lawrence
P356
10.1053/SRAO.2003.50002
P577
2003-01-01T00:00:00Z